A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Hi Sarah, We don't have a decision on those quite yet, we just removed "peta" and "petalatino" for now. Hoping to have a decision on Monday. Thanks! Anna
-
Hi Sarah, We don't have a decision on those quite yet, we just removed "peta" and "petalatino" for now. Hoping to have a decision on Monday. Thanks! Anna
-
Hi Sarah, We don't have a decision on those quite yet, we just removed "peta" and "petalatino" for now. Hoping to have a decision on Monday. Thanks! Anna
-
Great, thanks so much Anna! Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch 00 (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.
-
2021-12-03 13:16
Sarah J. Imhoff
Great, thanks so much Anna! Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.
-
Great, thanks so much Anna! Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.
-
Great, thanks so much Anna! Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such oo) (¢] <n > oe /OD) [.] : 00) oo) (¢] <n > oe Lankford, Lankford, Lankford, information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.
-
Hi Sarah, Since there were quite a few questions and requests for screenshots, we have compiled our responses in the attached word doc. Our answers to your questions are highlighted in yellow. Please let us know if you have any questions regarding the responses. We have two main questions for you and DOJ: 1. Can the chief policy maker just be NIH or do we have to name a specific person? We'd prefer to not name a specific person given the history of PETA sharing people's personal information with their supporters. OGC- David Lankford and I- would like to know the ultimate NIH decision-maker for this lawsuit. The person's name will not be given to Plaintiffs and is for our own internal coordination purposes only. 00) (] an > * -- oo) (¢] <n > oe 1/0D) [] aa a > 1/00) (] Lankford, Lankford, Lankford, 2. Our desired outcome is to still be able to moderate comments, specifically those comments that are off topic to the posts. Based on this desired outcome, which path would OGC recommend we take with this lawsuit? I will get back to you on this shortly after further discussion. Thank you, Anna
-
Hi Sarah, Since there were quite a few questions and requests for screenshots, we have compiled our responses in the attached word doc. Our answers to your questions are highlighted in yellow. Please let us know if you have any questions regarding the responses. We have two main questions for you and DOJ: 1. Can the chief policy maker just be NIH or do we have to name a specific person? We'd prefer to not name a specific person given the history of PETA sharing people's personal information with their supporters. OGC- David Lankford and I- would like to know the ultimate NIH decision-maker for this lawsuit. The person's name will not be given to Plaintiffs and is for our own internal coordination purposes only. OD) [E] ce : 00) () oo) I) <a > ee OD) [E] re : 00) Lankford, Lankford, Lankford, 2. Our desired outcome is to still be able to moderate comments, specifically those comments that are off topic to the posts. Based on this desired outcome, which path would OGC recommend we take with this lawsuit? I will get back to you on this shortly after further discussion. Thank you, Anna